multidrug resistant tuberculosis


Also found in: Dictionary, Thesaurus, Encyclopedia.

multidrug resistant tuberculosis

Abbreviation: MDR-TB
Mycobacterium tuberculosis bacilli that are resistant to therapy with at least two standard antitubercular drugs (esp. isoniazid and rifampin, the two drugs that have formed the cornerstone of therapy for tuberculosis). MDR-TB must be treated with at least three antitubercular drugs to which the organism is presumed or proven to be sensitive. About 3% of cases of TB are drug-resistant.
See also: tuberculosis
References in periodicals archive ?
Perucci, "Risk factors for multidrug resistant tuberculosis in Europe: a systematic review," Thorax, vol.
Effectiveness of a simplified short regimen for multidrug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan [cited 2015 May 20].
Trends in multidrug resistant tuberculosis. Pak J Chest Med 2001; 7:21-8.
This assessment, which the investigators call the first comprehensive set of estimates of the multidrug resistant tuberculosis burden, was based on the results of resistance surveys from numerous countries along with data considered predictive of resistance rates in many other countries.
Background: Multidrug resistant tuberculosis caused by Mycobacterium tuberculosis is an infection that is resistant to rifampicin and isoniazid.
Drug resistant and multidrug resistant tuberculosis. In: Clinical tuberculosis diagnosis and treatment.
Multidrug resistant tuberculosis contact investigation results at 2 sites, by HIV status and country of birth, New York, New York, USA * Site US-born, Foreign-born, no.
Prasad, "Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India," Indian Journal of Medical Microbiology, vol.
The 5-year outcome of multidrug resistant tuberculosis patients in the Cape Province of South Africa.

Full browser ?